International Assets Investment Management LLC Takes $204,000 Position in Abrdn Life Sciences Investors (NYSE:HQL)

International Assets Investment Management LLC acquired a new stake in shares of Abrdn Life Sciences Investors (NYSE:HQL) in the third quarter, HoldingsChannel reports. The firm acquired 13,507 shares of the company’s stock, valued at approximately $204,000.

A number of other institutional investors have also recently made changes to their positions in HQL. Future Financial Wealth Managment LLC bought a new position in shares of Abrdn Life Sciences Investors in the 3rd quarter valued at about $30,000. B. Riley Wealth Advisors Inc. bought a new position in shares of Abrdn Life Sciences Investors in the 1st quarter valued at about $143,000. Sanctuary Advisors LLC bought a new position in shares of Abrdn Life Sciences Investors in the 2nd quarter valued at about $154,000. Wedbush Securities Inc. lifted its holdings in shares of Abrdn Life Sciences Investors by 8.2% in the 2nd quarter. Wedbush Securities Inc. now owns 16,673 shares of the company’s stock valued at $236,000 after acquiring an additional 1,261 shares during the last quarter. Finally, Oppenheimer & Co. Inc. lifted its holdings in shares of Abrdn Life Sciences Investors by 4.6% in the 1st quarter. Oppenheimer & Co. Inc. now owns 18,414 shares of the company’s stock valued at $251,000 after acquiring an additional 814 shares during the last quarter. Hedge funds and other institutional investors own 32.21% of the company’s stock.

Abrdn Life Sciences Investors Stock Up 0.3 %

Shares of NYSE:HQL opened at $14.97 on Thursday. Abrdn Life Sciences Investors has a 12 month low of $11.62 and a 12 month high of $15.90. The company has a 50-day moving average price of $15.03 and a 200 day moving average price of $14.57.

Abrdn Life Sciences Investors Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, September 30th. Investors of record on Friday, August 23rd were issued a $0.49 dividend. This is an increase from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48. The ex-dividend date was Friday, August 23rd. This represents a $1.96 dividend on an annualized basis and a dividend yield of 13.09%.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.